U0267 Foam — Competitive Intelligence Brief

U0267 Foam (U0267 Foam) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical corticosteroid. Area: Dermatology.

phase 3 Topical corticosteroid Dermatology Small molecule

Target snapshot

U0267 Foam (U0267 Foam) — Stiefel, a GSK Company. U0267 Foam is a topical corticosteroid formulation designed to reduce inflammation and provide therapeutic benefit when applied directly to affected skin areas.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
U0267 Foam TARGET	U0267 Foam	Stiefel, a GSK Company	phase 3	Topical corticosteroid
Desoximetasone Spray 0.25%	Desoximetasone Spray 0.25%	Sun Pharmaceutical Industries, Inc.	marketed	Topical corticosteroid	Glucocorticoid receptor
Neo-Synalar Cream	Neo-Synalar Cream	Noah Rosenberg, MD	marketed	Topical corticosteroid	Glucocorticoid receptor
Mometasone furoate 0.1% cream	Mometasone furoate 0.1% cream	Montefiore Medical Center	marketed	Topical corticosteroid	Glucocorticoid receptor
Topical steroid	Topical steroid	University of South Alabama	marketed	Topical corticosteroid	Glucocorticoid receptor
Compound Clobetasol Propionate Ointment	Compound Clobetasol Propionate Ointment	First Hospital of China Medical University	marketed	Topical corticosteroid (Class I/super-potent)	Glucocorticoid receptor
Fluticasone proprionate 0.05% cream	Fluticasone proprionate 0.05% cream	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	marketed	Topical corticosteroid	Glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical corticosteroid class)

1. LEO Pharma · 3 drugs in this class
2. Pierre Fabre Medicament · 2 drugs in this class
3. GlaxoSmithKline · 2 drugs in this class
4. Promius Pharma, LLC · 2 drugs in this class
5. Astellas Pharma Inc · 1 drug in this class
6. Astion Pharma A/S · 1 drug in this class
7. Al-Azhar University · 1 drug in this class
8. BUZZZ Pharmaceuticals Limited · 1 drug in this class
9. Apotex Inc. · 1 drug in this class
10. Aswan University Hospital · 1 drug in this class